Corrigendum to: Mortality and morbidity in Cushing’s syndrome in New Zealand: Cushing’s syndrome mortality and morbidity (Clinical Endocrinology, (2011), 75, 4, (436-442), 10.1111/j.1365-2265.2011.04124.x);Mortality and morbidity in Cushing's syndrome in New Zealand

Clinical Endocrinology

Volumn 75, Issue 4, 2011, Pages 436-442

  Bolland, Mark J ^a   Holdaway, Ian M ^b   Berkeley, Juliet E ^c   Lim, Sarina ^d   Dransfield, Will J ^e   Conaglen, John V ^d   Croxson, Michael S ^b   Gamble, Greg D ^a   Hunt, Penny J ^c   Toomath, Robyn J ^e  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b GREEN LANE HOSPITAL   (New Zealand)

^c CHRISTCHURCH HOSPITAL   (New Zealand)

^d WAIKATO HOSPITAL   (New Zealand)

^e WELLINGTON HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADRENAL CORTEX ADENOMA; ADRENAL INSUFFICIENCY; ADULT; AGED; ARTICLE; CAUSE OF DEATH; CHILD; COMORBIDITY; CUSHING SYNDROME; DIABETES INSIPIDUS; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; FOLLOW UP; GROWTH HORMONE DEFICIENCY; HUMAN; HYPERTENSION; HYPOGONADISM; HYPOPHYSIS ADENOMA; HYPOTHYROIDISM; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MENTAL DISEASE; MORBIDITY; MORTALITY; MYOPATHY; NEW ZEALAND; NODULAR HYPERPLASIA; OSTEOPOROSIS; PITUITARY MACROADENOMA; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; SEXUAL DYSFUNCTION; STANDARDIZED MORTALITY RATIO; VASCULAR DISEASE;

EID: 80052526859     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.14249     Document Type: Erratum

References (18)

1. Etxabe, J., &, Vazquez, J.A., (1994) Morbidity and mortality in Cushing's disease: an epidemiological approach. Clin Endocrinol (Oxford), 40, 479-484. (Pubitemid 24194645)
2. Lindholm, J., Juul, S., Jorgensen, J.O., et al. (2001) Incidence and late prognosis of Cushing's syndrome: a population-based study. Journal of Clinical Endocrinology and Metabolism, 86, 117-123. (Pubitemid 32111743)
3. Plotz, C.M., Knowlton, A.I., &, Ragan, C., (1952) The natural history of Cushing's syndrome. American Journal of Medicine, 13, 597-614.
4. Bochicchio, D., Losa, M., &, Buchfelder, M., (1995) Factors influencing the immediate and late outcome of Cushing's disease treated by transsphenoidal surgery: a retrospective study by the European Cushing's disease survey group. Journal of Clinical Endocrinology and Metabolism, 80, 3114-3120.
5. Porterfield, J.R., Thompson, G.B., Young Jr, W.F., et al. (2008) Surgery for Cushing's syndrome: an historical review and recent ten-year experience. World Journal of Surgery, 32, 659-677.
6. Swearingen, B., Biller, B.M., Barker 2nd, F.G., et al. (1999) Long-term mortality after transsphenoidal surgery for Cushing disease. Annals of Internal Medicine, 130, 821-824. (Pubitemid 29231150)
7. Pikkarainen, L., Sane, T., &, Reunanen, A., (1999) The survival and well-being of patients treated for Cushing's syndrome. Journal of Internal Medicine, 245, 463-468. (Pubitemid 29232235)
8. Dekkers, O.M., Biermasz, N.R., Pereira, A.M., et al. (2007) Mortality in patients treated for Cushing's disease is increased, compared with patients treated for nonfunctioning pituitary macroadenoma. Journal of Clinical Endocrinology and Metabolism, 92, 976-981. (Pubitemid 46465672)
9. Clayton, R.N., Raskauskiene, D., Reulen, R.C., et al. (2011) Mortality and morbidity in Cushing's disease over 50 years in stoke-on-trent, UK: audit and meta-analysis of literature. Journal of Clinical Endocrinology and Metabolism, 96, 632-642.
10. National Ethics Advisory Committee (2006) Ethical Guidelines for Observational Studies: Observational Research, Audits and Related Activities. Ministry of Health, Wellington.
11. Woodward, M., (2005) Epidemiology: Study Design and Data Analysis, 2nd edn. Chapman & Hall/CRC, Boca Raton.
12. Welbourn, R.B., (1985) Survival and causes of death after adrenalectomy for Cushing's disease. Surgery, 97, 16-20. (Pubitemid 15244871)
13. Grabner, P., Hauer-Jensen, M., Jervell, J., et al. (1991) Long-term results of treatment of Cushing's disease by adrenalectomy. European Journal of Surgery, 157, 461-464.
14. O'Riordain, D.S., Farley, D.R., Young Jr, W.F., et al. (1994) Long-term outcome of bilateral adrenalectomy in patients with Cushing's syndrome. Surgery, 116, 1088-1093. discussion 1093-1084.
15. Hammer, G.D., Tyrrell, J.B., Lamborn, K.R., et al. (2004) Transsphenoidal microsurgery for Cushing's disease: initial outcome and long-term results. Journal of Clinical Endocrinology and Metabolism, 89, 6348-6357. (Pubitemid 39628458)
16. Sherlock, M., Reulen, R.C., Alonso, A.A., et al. (2009) ACTH deficiency, higher doses of hydrocortisone replacement, and radiotherapy are independent predictors of mortality in patients with acromegaly. Journal of Clinical Endocrinology and Metabolism, 94, 4216-4223.
17. Sherlock, M., Ayuk, J., Tomlinson, J.W., et al. (2010) Mortality in patients with pituitary disease. Endocrine Reviews, 31, 301-342.
18. Colao, A., Pivonello, R., Spiezia, S., et al. (1999) Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure. Journal of Clinical Endocrinology and Metabolism, 84, 2664-2672. (Pubitemid 30641990)